Showing results (681-690 of 829) with videos related to
Sort By:
Pageof 83
Biorxiv : the Preprint Server for Biology|October 10, 2024
MALT1 protease inhibition restrains glioblastoma progression by reversing tumor-associated macrophage-dependent immunosuppressionJuliana Hofstätter Azambuja, Saigopalakrishna S Yerneni, Lisa M Maurer, et al.Breast Cancer Research : BCR|December 10, 2016
MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinibAdelaide I J Young, Andrew M K Law, Lesley Castillo, et al.Cell Reports|September 30, 2016
MALT1 Protease Activation Triggers Acute Disruption of Endothelial Barrier Integrity via CYLD CleavageLinda R Klei, Dong Hu, Robert Panek, et al.Journal of Medicinal Chemistry|August 11, 2012
Potent and highly selective benzimidazole inhibitors of PI3-kinase deltaJeremy M Murray, Zachary K Sweeney, Bryan K Chan, et al.Journal of Fish Biology|November 20, 2025
Inshore marine coastal zone migration patterns in Atlantic salmon post-smolts emigrating from eight rivers in north-east ScotlandColin E Adams, Ruaidhri Forrester, Matthew Newton, et al.Journal for Immunotherapy of Cancer|October 20, 2019
Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumorsLi Zhu, Jessica L Narloch, Sayali Onkar, et al.Bioorganic & Medicinal Chemistry Letters|October 29, 2008
Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitorsLinda M Bannwart, David S Carter, Hai-Ying Cai, et al.Journal of the National Cancer Institute|March 20, 2019
Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast CancerRim S Kim, Nan Song, Patrick G Gavin, et al.Biorxiv : the Preprint Server for Biology|March 27, 2026
Estrogen receptor-positive cell line xenograft models recapitulate metastatic dissemination and endocrine response of invasive lobular breast carcinomaNilgun Tasdemir, Laura Savariau, Julie Scott, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2020
Neratinib-Plus-Cetuximab in Quadruple-WT (KRAS, NRAS, BRAF, PIK3CA) Metastatic Colorectal Cancer Resistant to Cetuximab or Panitumumab: NSABP FC-7, A Phase Ib StudySamuel A Jacobs, James J Lee, Thomas J George, et al.Pageof 83